MedTrace Logo

Injecting Drug Use Community Intervention Trial

NCT01108614 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 12000

Last updated 2010-05-07

No results posted yet for this study

Summary

The purpose of this study is to reduce the HIV/HCV incidence among the clients attending community-based methadone maintenance treatment (MMT) , and to prevent the secondary sexual transmission from HIV+ clients to their spouse and sex partners, through intensified comprehensive intervention.

Conditions

  • HIV
  • Hepatitis C
  • Syphilis
  • HSV-2
  • HIV Infections

Interventions

BEHAVIORAL

Intervention

Intensive HIV psychological counseling ,Increased methadone dosage under individualized treatment principle, enhance randomized urine test, strengthen family and social support , partner notification and routine HIV testing, condom promotion, STD referral services.

Sponsors & Collaborators

  • Yunnan Center for Disease Control and Prevention

    collaborator OTHER

  • Xinjiang Center for Disease Control and Prevention

    collaborator OTHER

  • Sichuan Center for Disease Control and Prevention

    collaborator OTHER_GOV

  • Guangxi Center for Disease Control and Prevention

    collaborator OTHER_GOV

  • Guizhou Center for Disease Control and Prevention

    collaborator OTHER

  • National Center for AIDS/STD Control and Prevention, China CDC

    lead OTHER_GOV

Principal Investigators

  • Zunyou Wu, MD, PHD · National Center for AIDS/STD Control and Prevention, China CDC

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-06-30
Primary Completion
2010-12-31
Completion
2011-03-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01108614 on ClinicalTrials.gov